Identifying The Need For Neoadjuvant Chemotherapy In Stage I Breast Cancer

Identifying the need for neoadjuvant chemotherapy in stage I breast cancer

Breast Cancer Neoadjuvant Chemotherapy: For Patients

Breast Cancer School for Patients

Will I need Chemotherapy for My Breast Cancer?

Breast Cancer School for Patients

Gene expression assays to identify patients with breast cancer for neoadjuvant treatment

Indications for Neoadjuvant Therapy in Breast Cancer Therapy

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Exploring Neoadjuvant Therapy for Breast Cancer: What You Need to Know

Yerbba – Breast Cancer

Dr. King on Neoadjuvant Chemotherapy in Breast Cancer

Dr. Terry Mamounas on Neoadjuvant Chemotherapy for Early-Stage Breast Cancer

TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy

Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

Dr. Mamounas on Selecting Patients With Breast Cancer for Neoadjuvant Chemotherapy

RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

Do I Need Preoperative Chemotherapy for My Breast Cancer?

Yerbba – Breast Cancer

Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)?

Dr. Sledge on Using PCR To Determine Therapy Benefit for Breast Cancer

Chemotherapy in Early-Stage gBRCA1/2+ Breast Cancer

Neoadjuvant talazoparib active in BRCA-mutated early breast cancer | Jennifer Litton

Medicine Matters oncology

Breast Cancer Type and Stage: What You Need to Know

Breast Cancer School for Patients